Welcome to our dedicated page for DALRADA FINCL news (Ticker: DFCO), a resource for investors and traders seeking the latest updates and insights on DALRADA FINCL stock.
Dalrada Financial Corporation, through its subsidiaries, provides various products and services in the manufacturing, engineering, and healthcare sectors worldwide. The company offers low-carbon heating and cooling systems, visual inspection kits for detecting cervical cancer, and software solutions in test engineering, accessibility engineering, and more. Additionally, it provides cleaning solutions with electrostatic machines for various facilities. Formerly known as Imaging Technologies Corporation, Dalrada Financial Corporation was incorporated in 1982 and is headquartered in Escondido, California.
The company, under the leadership of CEO Brian Bonar, focuses on driving innovation in the Clean Energy and Health Care sectors. Its segments include Dalrada Climate Technology and Genefic Specialty Pharmacy, offering advanced heat pump technology and end-to-end prescription services, respectively. With a commitment to sustainability and cutting-edge solutions, Dalrada Financial Corporation aims to deliver value to its shareholders.
Dalrada Financial Corp. (OTCQB: DFCO) announces a partnership between its subsidiary, Prakat Solutions, Inc., and Dragonchain, Inc. This collaboration aims to enhance business workflow efficiencies focused on accountability and supply chain transparency. Utilizing Dragonchain's patented blockchain technology, Prakat will develop secure and scalable applications across sectors such as clean energy, finance, healthcare, education, and manufacturing. The partnership highlights blockchain's potential in real-time data access and maintaining data privacy.
Dalrada Financial Corp. (OTCQB: DFCO) is pleased to report the initial purchase of its LikidoVOLT® Clean Energy generators by Hidden Villa Ranch, a leading distributor of organic eggs and dairy. This highlights the growing adoption of Dalrada's sustainable technology solutions, which include energy-efficient generators that operate 24/7 and utilize dry fuel sources. Accelerated production is underway to meet customer demand, with plans for demonstration units to be available soon. The company's commitment to supporting the Paris Climate Agreement underscores its alignment with global sustainability goals.
Dalrada Financial Corp. (DFCO) announces entry into the global genomics market with its product portfolio, Empower Genomics. This initiative stems from increasing demand for precision medicine and includes tests for pharmacogenomics and alternative therapies such as nutrition and fitness analysis. The global genomics market is projected to reach USD 54.4 billion by 2025, growing at a CAGR of 19.0% from USD 22.7 billion in 2020. Dalrada Health aims to address global health problems while utilizing advanced technology and analytics.
Dalrada Financial Corp. (OTCQB: DFCO) announces that David Pickett has been appointed as Executive Vice President of Sales and Business Development, effective immediately. Previously serving as Vice President of Business Development since 2017, Pickett will oversee global sales efforts across Dalrada's portfolio, including Engineering, Technology, Science, Health, and Clean Energy. His extensive experience, including work with Fortune 500 companies, positions him to drive growth in Dalrada's initiatives, especially in alternative health products and Clean Energy.
Dalrada Financial Corp. (OTCQB: DFCO) announced the accelerated production of its LikidoVOLT® Clean Energy generators, which boast energy efficiencies exceeding 90%. These generators use propane or natural gas, providing continuous off-grid power for residential and commercial uses. Manufactured in partnership with Tongrun International in Texas, LikidoVOLT will start shipping by the end of Q2 2021. CEO Brian Bonar emphasized the significance of these generators in addressing power outages caused by natural disasters, while also providing cost savings and reducing carbon emissions.
Dalrada Financial Corp. (OTCQB: DFCO) announced the appointment of Tom Giles to its Board of Directors on February 17, 2021. Mr. Giles brings extensive experience in technology and healthcare, particularly in artificial intelligence and machine learning. He has successfully raised over $200 million for startups and established partnerships with major companies like IBM and T-Mobile. CEO Brian Bonar expressed confidence that Giles' leadership will accelerate growth in the technology and clean energy sectors.
Dalrada Financial Corp. (OTCQB: DFCO) reported a remarkable 3,181% increase in revenues, totaling $1,055,517 for the three months ending September 30, 2020. This marks the company's best quarter since its strategic shift in 2018 towards science, engineering, and technology. The gross profit was 57%, although slightly down from the previous quarter. Despite the strong revenue growth, the company experienced a net income loss due to expansion efforts and rising operational costs. Management remains optimistic, citing significant demand and expansion opportunities.
Dalrada Financial Corp. (OTCQB: DFCO) announces the appointment of Anthony Zolezzi to its Board of Directors. Zolezzi, known for his commitment to sustainability, aims to enhance Dalrada's green energy initiatives. He has a proven track record with ventures like Bubba Gump Shrimp Co. and partnerships with major brands like Walmart and PepsiCo. His experience includes promoting organic agriculture and recycling projects. CEO Brian Bonar emphasizes that Zolezzi's expertise will be vital for furthering the company's sustainability goals amid growing climate change concerns.
Dalrada Financial Corp. (OTCQB: DFCO) announced the acquisition of Pacific Stem Cells, LLC, enhancing its healthcare offerings with non-invasive therapies. This strategic move is anticipated to boost Dalrada's annualized revenue by $2.5MM over the next year. Pacific Stem Cells, recognized for its high-quality regenerative treatments, aims to address various medical conditions, including those related to aging and COVID-19. The global stem cells market is projected to reach USD 17.9 billion by 2027, presenting significant growth potential for Dalrada Health Products.
Dalrada Financial Corp. (OTCQB: DFCO) announced its acquisition of International Health Group, Inc. (IHG), a healthcare training organization. This acquisition aims to enhance healthcare staffing, especially for COVID-19 vaccination efforts in Southern California. IHG, which has trained nearly 7,000 medical professionals since 2006, is projected to generate $1MM in annual revenue within a year. CEO Brian Bonar highlighted the strategic significance of this acquisition for staffing solutions in nursing and home health. With the U.S. healthcare staffing market valued at $17 billion, this move positions Dalrada for substantial growth.
FAQ
What is the current stock price of DALRADA FINCL (DFCO)?
What is the market cap of DALRADA FINCL (DFCO)?
What products and services does Dalrada Financial Corporation offer?
When was Dalrada Financial Corporation incorporated?
Where is Dalrada Financial Corporation headquartered?
Who is the CEO of Dalrada Financial Corporation?
What are the core segments of Dalrada Financial Corporation?
What is the focus of Dalrada Financial Corporation?
What is the mission of Dalrada Financial Corporation?
